Dr Leslie Kantor on Communicating Importance of Receiving Both Flu, COVID-19 Vaccines
November 12th 2021Leslie Kantor, PhD, MPH, chair and professor of the Department of Urban-Global Public Health, Rutgers School of Public Health, discusses the key messages that people need to hear about the continued importance of the flu vaccine, even if they have been immunized for COVID-19.
Watch
High Iron Levels in Blood Linked to Increased Risk of Liver Cancer in NAFLD
November 12th 2021Researchers conducted the study because although prior research has illustrated that elevated levels of iron in the blood from hereditary hemochromatosis can raise the risk of liver cancer, little is known about the effect of this condition in nonalcoholic fatty liver disease (NAFLD).
Read More
Health Equity, Heart Failure, and Technology on Agenda at AHA Scientific Sessions
November 11th 2021Solutions for health equity, treatments for heart failure, and the use of technology in prevention and patient care are just some of the topics on the agenda for the 2021 American Heart Association (AHA) Scientific Sessions, which will take place Saturday through Monday in a virtual format.
Read More
ASOPRS Orbit Session Details New Data on Malpositioned Implants, Orbital Compartment Syndrome
November 11th 2021At the American Society of Ophthalmic Plastic & Reconstructive Surgery's 2021 Fall Scientific Symposium, presentations on orbital complications included research on poorly positioned implants and factors associated with orbital compartment syndrome.
Read More
Growth Hormone Therapy Risk, Safety in Pediatric Cancer Survivors Profiled
November 11th 2021Because treatment with growth hormone (GH), often necessitated by GH deficiency from childhood cancer, has been linked to tumorigenesis, concerns remain around its use among childhood cancer survivors.
Read More
Analysis of Nusinersen Shows Favorable Safety Profile in Adults With SMA
November 11th 2021Data on nusinersen’s safety profile in adult patients are more limited than in infant and adolescent patients, but a recent study showed positive results based on cerebrospinal fluid and blood sample parameters.
Read More
Dr Robert Gabbay: Diabetes Clinical Trials Should Be More Inclusive
November 11th 2021Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, explains why clinical trials need to be inclusive and how the Health Equity Now initiative is working to recruit more diverse populations with diabetes.
Watch
New Research Underscores Need for More Diversity in Precision Oncology Studies
November 11th 2021Across all studies included, observed-to-expected ratios showed that White and Asian patients were overrepresented while Black patients, Hispanic patients, and American Indian/Alaskan Native patients were underrepresented.
Read More
Dr Seth Martin on the mTECH Center and Digital Divides
November 11th 2021Seth Martin, MD, MHS, associate professor of medicine at Johns Hopkins University and co-director of the Center for Mobile Technologies to Achieve Equity in Cardiovascular Health (mTECH Center), gives a preview of his presentation on digital divides at the American Heart Association (AHA) Scientific Sessions 2021.
Watch
Real-world Data Highlight Benefits of Teprotumumab for Thyroid Eye, Graves Diseases
November 11th 2021Study findings presented at the American Society of Ophthalmic Plastic & Reconstructive Surgery's 2021 Fall Scientific Symposium detail the benefits of teprotumumab for thyroid eye disease.
Read More
What We’re Reading: Measles Outbreaks Possible; NIH vs Moderna; Mental Health Benefits Expand
November 11th 2021The World Health Organization and CDC warn of the potential for measles outbreaks; the National Institutes of Health (NIH) and Moderna battle over patent rights to Moderna’s COVID-19 vaccine; a new Kaiser Family Foundation shows employers have increased mental health care offerings.
Read More
A National Perspective of the Opportunities, Challenges Facing Health Care Cost and Sustainability
November 11th 2021Michael E. Chernew, PhD, co-editor-in-chief of The American Journal of Managed Care®, discussed cost and sustainability issues specific to commercial insurance, Medicare, and Medicaid at the National Alliance 2021 Annual Forum held in a hybrid format in Washington, DC.
Read More
Contributor: When It Comes to Maternal Health, States Can Be Health Plans’ North Star
November 11th 2021States are turning to alternative payment models to improve outcomes and reduce health care expenditures, representing a critical step forward specifically for the US maternal health crisis.
Read More
Study Identifies Factors Influencing the Degree of Disability in MS
November 10th 2021Drug use, serum albumin, and total number of lesions may serve as independent factors influencing the degree of disability in patients with multiple sclerosis (MS), investigators of a retrospective analysis concluded.
Read More
Anticholinergic Polypharmacy in Medicare Not Common but Still Problematic, Study Says
November 10th 2021The share of patients meeting the definition of polypharmacy for the condition of overactive bladder declined from 2006 to 2017, but the phenomenon was still prevalent in women and patients in nursing homes, according to a recent study.
Read More
Dr Robert Gabbay on COVID-19 Vaccinations in the Diabetes Community
November 10th 2021Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, discusses COVID-19 vaccinations among people with diabetes as they have been disproportionally affected by the pandemic.
Watch
Dr Tiffany Powell-Wiley on Social Factors of Obesity and Cardiovascular Disease
November 10th 2021Tiffany Powell-Wiley, MD, MPH, a Stadtman investigator and chief of the Social Determinants of Obesity and Cardiovascular Risk Laboratory at the National Heart, Lung, and Blood Institute, with a joint appointment at the National Institute on Minority Health and Health Disparities, discusses ongoing trials and the American Heart Association’s Scientific Statement on social determinants of obesity and cardiovascular disease.
Watch
The Supreme Court of Oklahoma ruled that Johnson & Johnson cannot be held liable for the state’s opioid crisis; a trial found the psychedelic drug psilocybin may be a highly efficacious therapy for treatment-resistant depression; people who went to bed at midnight or later had a 25% greater risk of cardiovascular disease.
Read More
Mortality Increase Seen in Patients With Heart Failure, Hypercapnia
November 10th 2021Outcomes of in-hospital mortality, 7-day mortality, and emergency department length of stay were investigated among a cohort of patients with acute heart failure and hypercapnia, or excessive levels of CO2 in the blood.
Read More